Physician

Mohammad N Al Shroof, M.D.

According to 2025 Medicare claims, Mohammad Shroof, M.D. (NPI: 1578519286) practices internal medicine in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is SOUTHEAST MEDICAL GROUP, P.C. (NPI: 1235296054; TIN: 581896468) and primary practice location at 31093-3634. Shroof is affiliated with the TC2, LLC (ACO ID: A3365) and Southeast Quality Network, LLC (ACO ID: A5337), participating under the MSSP model.

Shroof's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,911 traditional Medicare patients, billed 36,785 HCPCS/CPT codes, and received $1,136,607 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 35,541 prescription claims across 1,847 beneficiaries totaling $3,832,124 in drug costs, led by Ozempic (Semaglutide). DME data shows 836 claims. Open Payments data shows 187 records totaling $3,418. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $534,584 to $1,136,607. Similarly, Part D prescription costs have risen steadily, from $1,863,196 to $3,832,124. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $93,387 to $120,614.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,869	30,439	$534,584
2016	1,959	42,807	$741,356
2017	1,978	55,818	$848,705
2018	2,477	50,972	$966,538
2019	2,751	44,051	$1,043,797
2020	2,543	38,676	$1,022,873
2021	2,577	48,543	$1,102,372
2022	2,258	51,155	$1,255,084
2023	1,991	46,168	$1,039,571
2024	1,911	36,785	$1,136,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	968	30,299	$1,863,196
2016	1,082	29,238	$2,034,952
2017	1,142	36,374	$2,145,374
2018	1,158	31,506	$2,751,314
2019	1,208	30,863	$3,031,589
2020	1,314	33,762	$3,005,937
2021	1,436	33,282	$3,237,079
2022	1,376	31,607	$3,092,781
2023	1,645	34,790	$3,960,934
2024	1,847	35,541	$3,832,124

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	400	1,644	$98,536
2016	371	1,698	$92,359
2017	249	1,541	$54,239
2018	328	1,629	$61,627
2019	198	1,131	$44,640
2020	171	879	$74,182
2021	131	866	$87,362
2022	79	1,067	$109,986
2023	111	1,201	$168,646
2024	76	836	$87,510

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,002	2,894	$89
99497	Advance care planning, first 30 minutes	687	693	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	672	1,665	$63
G0444	Annual depression screening, 5 to 15 minutes	708	762	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	985	3,489	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	292	13,279	$397,870
Eliquis	Apixaban	575	16,851	$332,895
Mounjaro	Tirzepatide	225	8,294	$312,517
Jardiance	Empagliflozin	235	9,911	$197,587
Farxiga	Dapagliflozin Propanediol	146	7,743	$138,209

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	65	$23,924
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,065
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	55	$8,456
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	35	$7,649
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	21	$6,628

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	187	$3,418	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammad N. Al Shroof, M.D.?

Tedicare shows public-source Medicare data for Mohammad N. Al Shroof, M.D. (NPI 1578519286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad N. Al Shroof, M.D. have ACO affiliation data?

Mohammad N. Al Shroof, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365) and Southeast Quality Network, LLC (MSSP, ACO ID A5337).

What billing organization is linked to Mohammad N. Al Shroof, M.D.?

Mohammad N. Al Shroof, M.D. is linked to SOUTHEAST MEDICAL GROUP, P.C. (billing NPI 1235296054) in the available physician profile data.

Does Mohammad N. Al Shroof, M.D. have Open Payments data?

Mohammad N. Al Shroof, M.D. has 187 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.